Clinical Trial Update: To Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Food Effects of LY03021 in Healthy Chinese Subjects [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing safety, tolerability, pharmacokinetics, and food effects of LY03021 in healthy Chinese subjects, with Major Depressive Disorder…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• LY03021

Snippet

Sponsor: Luye Pharma Group Ltd. | Conditions: Major Depressive Disorder | Phase 1 | Status: ENROLLING_BY_INVITATION